Live Breaking News & Updates on Analyst Recommendations For Amneal Pharmaceuticals

Stay updated with breaking news from Analyst recommendations for amneal pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Recommendation of "Moderate Buy" from Analysts

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the five research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target […] ....

Hong Kong , United States , Tower Research Capital , Amneal Pharmaceuticals Trading , Pricet Rowe Associates Inc , Y Intercept Hong Kong Ltd , News Ratings For Amneal Pharmaceuticals Daily , American Century Companies Inc , Analyst Recommendations For Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Institutional Trading Of Amneal Pharmaceuticals , Amneal Pharmaceuticals , Get Free Report , Century Companies , Gate Manager , Research Capital , Get Free , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $4.80 Consensus Target Price from Analysts

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have received a consensus rating of “Moderate Buy” from the five ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 […] ....

United States , Hong Kong , Amneal Pharmaceuticals Company Profile , Institutional Investors Weigh In On Amneal Pharmaceuticals , Analyst Recommendations For Amneal Pharmaceuticals , Pricet Rowe Associates Inc , Amneal Pharmaceuticals Inc , Tower Research Capital , Amneal Pharmaceuticals , American Century Companies Inc , Y Intercept Hong Kong Ltd , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Price Performance , Get Free Report , Marketbeat Ratings , Century Companies , Gate Manager , Research Capital , Get Free , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

StockNews.com Begins Coverage on Amneal Pharmaceuticals (NASDAQ:AMRX)

StockNews.com assumed coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a research note published on Wednesday morning. The firm issued a buy rating on the stock. Separately, Truist Financial boosted their target price on Amneal Pharmaceuticals from $6.00 to $7.00 and gave the stock a buy rating in a research note on […] ....

Amneal Pharmaceuticals Company Profile , Millennium Management , Amneal Pharmaceuticals , News Ratings For Amneal Pharmaceuticals Daily , Blackrock Inc , Vanguard Group Inc , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Stock Performance , Analyst Recommendations For Amneal Pharmaceuticals , Morgan Stanley , Free Report , Truist Financial , Moderate Buy , Get Free Report , Rubric Capital Management , Capital Management , Amneal Pharmaceuticals Daily , Nasdaq Amrx , Initiated Coverage , Stocknews Com ,

Amneal Pharmaceuticals (NASDAQ:AMRX) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a report published on Wednesday. The firm issued a buy rating on the stock. Separately, Truist Financial upped their target price on Amneal Pharmaceuticals from $6.00 to $7.00 and gave the company a buy rating in a research report on Wednesday, November […] ....

United States , Amneal Pharmaceuticals Stock Down , American Century Companies Inc , Vanguard Group Inc , Amneal Pharmaceuticals Company Profile , Amneal Pharmaceuticals , Jacobs Levy Equity Management Inc , News Ratings For Amneal Pharmaceuticals Daily , Analyst Recommendations For Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Free Report , Truist Financial , Moderate Buy , Pharmaceuticals Stock Down , Get Free Report , Employees Retirement System , Capital Management , Century Companies , Jacobs Levy Equity Management , Levy Equity Management , Amneal Pharmaceuticals Daily , Nasdaq Amrx , Initiated Coverage , Stocknews Com ,

Amneal Pharmaceuticals (NASDAQ:AMRX) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) in a research note issued to investors on Tuesday morning. The brokerage issued a buy rating on the stock. Separately, Truist Financial upped their price objective on shares of Amneal Pharmaceuticals from $6.00 to $7.00 and gave the company a buy rating in […] ....

Millennium Management , Analyst Recommendations For Amneal Pharmaceuticals , Institutional Trading Of Amneal Pharmaceuticals , Amneal Pharmaceuticals , Vanguard Group Inc , Amneal Pharmaceuticals Stock , Amneal Pharmaceuticals Inc , Blackrock Inc , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Company Profile , Morgan Stanley , Free Report , Truist Financial , Moderate Buy , Get Free Report , Rubric Capital Management , Capital Management , Amneal Pharmaceuticals Daily , Nasdaq Amrx , Initiated Coverage , Stocknews Com ,